Connect with us

Industry

Medical cannabis cultivation gets green light in Guernsey

Businesses can now apply for a licence to grow high-THC cannabis for medical purposes.

Published

on

It marks a significant step in the island's emerging cannabis industry

Businesses based in the Bailiwick of Guernsey can now apply for a licence to grow high-THC cannabis for medical purposes.

In a significant step in the development of the island’s emerging cannabis industry, businesses can now apply for a high-THC cannabis cultivation licence following a Memorandum of Understanding (MoU) with the UK Home Office. 

Previously only licences to cultivate cannabis for CBD products were available. 

According to a Government announcement on Thursday 22 July, applications will be received by the newly formed Bailiwick of Guernsey Cannabis Agency (BGCA), which has been established by the Committee for Health and Social Care.

“Guernsey was one of the first to recognise the potential benefits that cannabis-based products medicinal might bring,” commented Deputy Al Brouard, president of the Committee for Health and Social Care.

“The MoU marks the start of a process that may allow these products to be produced on island for the benefit of patients within the Bailiwick and overseas. The creation of the Bailiwick of Guernsey Cannabis Agency further enhances our robust regulatory system for cannabis cultivation.”

Deputy Neil Inder, president of the Committee for Economic Development added: “Guernsey’s famous growing heritage continues to thrive within this new island industry. The MoU ensures that the Bailiwick can continue to remain at the forefront of a developing sector that provides diversification to our economy, revitalisation of our environment and new opportunities for skills and employment. 

“Growers once moved into finance and now finance is moving into growing. The Committee will continue to support the opportunities available in the pharmaceutical industry and I’m very grateful for the effort all parties have made to deliver the long-awaited MoU.”

Sarah Sinclair is an award-winning freelance journalist covering health, drug policy and social affairs. She is one of the few UK reporters specialising in medical cannabis policy and as the former editor of Cannabis Health has covered developments in the European cannabis sector extensively, with a focus on patients and consumers. She continues to report on cannabis-related health and policy for Forbes, Cannabis Health and Business of Cannabis and has written for The i Paper, Byline Times, The Lead, Positive News, Leafie & others. Sarah has an NCTJ accreditation and an MA in Journalism from the University of Sunderland and has completed additional specialist training through the Medical Cannabis Clinicians Society in the UK. She has spoken at leading industry events such as Cannabis Europa.

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2024 PP Intelligence Ltd.